Results 171 to 180 of about 2,176,861 (324)
Randomized controlled study of nemolizumab in patients with chronic kidney disease-associated pruritus: NIKAIA-1 [PDF]
Vandana S. Mathur +10 more
openalex +1 more source
Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo. [PDF]
Royeck S +10 more
europepmc +1 more source
ABSTRACT Linerixibat, an ileal bile acid transporter (IBAT) inhibitor, is being evaluated for the treatment of pruritus in primary biliary cholangitis (PBC). Diarrhea is commonly reported with this drug class as IBAT inhibition redirects bile acids (BA) to the colon.
Fernando Carreño +4 more
wiley +1 more source
High burden and suboptimal management of uremic pruritus among chronic kidney disease patients in Sennar state, Sudan: A cross-sectional study [PDF]
Abdulrahman Abdullahi Ishag +4 more
openalex +1 more source
The polysaccharide Pullulan improves the initial steps of allergen‐specific immunotherapy in dogs
Abstract Background Allergen‐specific immunotherapy (AIT) is the only aetiological treatment for canine atopic dermatitis (CAD). Pullulan, a polysaccharide with immunomodulatory properties, may enhance AIT outcomes when combined with allergens such as recombinant Dermatophagoides farinae 2 (Der f 2).
Franco Martini +3 more
wiley +1 more source
Chronic Kidney Disease–Associated Pruritus in Danish Dialysis Patients: A Cross-Sectional Multicenter Study of Prevalence, Disease Burden, and Current Treatment Practices [PDF]
Gustav Østerlund Larsen +9 more
openalex +1 more source
ABSTRACT Background Tapinarof cream 1%, a non‐steroidal topical aryl hydrocarbon receptor‐modulating agent, is approved in Japan for atopic dermatitis (AD) and plaque psoriasis. Real‐world data on longitudinal outcomes, treatment continuation, interruption and restart, and adverse‐event timing are limited. Methods This single‐center retrospective study
Kanade Iino +2 more
wiley +1 more source

